Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03576560

Acronym

Chorio

Enrollment

768

Registered

2018-07-03

Start date

2017-06-26

Completion date

2019-05-01

Last updated

2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chorioamnionitis

Brief summary

Retrospective Chart Review to determine the selective use of antibiotics in neonates born to mothers with suspected chorioamnionitis

Detailed description

To determine the incidence and types of adverse outcomes in infants born to mothers with signs of chorioamnionitis when these infants are asymptomatic and are not treated with antibiotics empirically.

Interventions

OTHERRetrospective Chart Review

Retrospective Chart Review

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

35 Weeks to 42 Weeks

Healthy volunteers

Inclusion criteria

• Mother/baby dyads in which the mother was diagnosed with chorioamnionitis and/or had intrapartum fever (as diagnosed by obstetrician)

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame	Description
Infants born to mother with chorioamnionitis/intrapartum fever as assessed by chart review.	Infants born from July, 2012 to December 31, 2018.	The retrospective chart review would analyze the total number of infants born to mothers with chorioamnionitis/intrapartum fever.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026